Website News and Research

RSS

Dartmouth Atlas hospital ratings could be misleading, says former CMS Senior Policy Advisor

A "Perspective" piece in today's New England Journal of Medicine by Peter B. Bach, MD, MAPP, points out that policy makers are relying on hospital ratings from the Dartmouth Atlas that could be misleading.

18 Feb 2010

URAC to conduct workshop highlighting multiple aspects of medication adherence

URAC, the nation's leading health care accreditation and education organization, will conduct a workshop on "Medication Adherence and Medication Possession Ratio as a Critical Metric" at the 15th Annual Pharmacy Benefit Management Institute (PBMI) Conference in Phoenix, Ariz.

18 Feb 2010

Results indicate deficiencies in end-of-life care across U.S.

Approximately 66 percent of respondents to a Maryland telephone survey do not have advance medical directives, according to a new report by researchers from the Johns Hopkins Bloomberg School of Public Health's Department of Health Policy and Management.

18 Feb 2010

Fourth-quarter and full-year 2009 results announced by Health Grades

Health Grades, Inc., the leading independent healthcare ratings company, today reported financial results for the fourth quarter and year ended December 31, 2009.

18 Feb 2010

The Ensign Group announces record $542.0M total revenue for full-year 2009

The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, today reported record results for the fourth quarter and full year 2009.

18 Feb 2010

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

Cannabis Science Inc., an emerging pharmaceutical cannabis company, is reviewing interim results of its survey from over 1400 people, US military veterans and others who responded to our PTSD survey. The survey is still available for a limited time online on the www.cannabisscience.com website for all those who still wish to participate.

17 Feb 2010

CDA, OneAmerica Financial Partners to educate American workforce on disability planning

The Council for Disability Awareness (CDA) is pleased to announce that OneAmerica Financial Partners, Inc. has joined the CDA to help raise awareness about the importance of disability planning and prevention.

17 Feb 2010

Siemens Healthcare to host first free Virtual Healthcare IT Conference on the use of EHR

On February 23, Siemens Healthcare kicks off its first in a series of free Virtual Healthcare IT Conferences. The conference, accessed at www.siemens.com/virtual-ARRA, will provide insights on achieving Meaningful Use of electronic health records, tied to the HITECH provision of President Barack Obama's American Recovery & Reinvestment Act (ARRA), and how health IT technology can help propel organizations to exceptional achievements in the delivery of healthcare services.

17 Feb 2010

Canada's first-ever national physiotherapy advertising campaign

Today marks the launch of the first-ever national advertising campaign in the 90-year history of physiotherapy in Canada. Commercials about physiotherapy will air on the CTV national network, TSN, and Sportsnet during coverage of the 2010 Winter Olympics in Vancouver when large numbers of Canadians will be tuning in. The ads will also be appearing on CBC's News Network and TVA's Salut Bonjour. A companion print ad will follow to extend the reach of the message, in time for May, which is National Physiotherapy Month.

17 Feb 2010

Sirona Dental Systems files prospectus supplement to its existing shelf registration statement

Sirona Dental Systems, Inc., today announced that it is filing a prospectus supplement to its existing shelf registration statement with the U.S. Securities and Exchange Commission relating to an underwritten public offering by Sirona Holdings Luxco S.C.A. of 7,000,000 shares of its common stock and 250,000 shares by Jeffery Slovin.

17 Feb 2010

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Covidien, a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland today announced an agreement to augment and further diversify Covidien’s supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

17 Feb 2010

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).

17 Feb 2010

Digestive care expert Brenda Watson's website discusses bowel movements and underlying health

Digestive Care Expert Brenda Watson’s new website takes a different look at poop with “The Poop Chronicles,” an eye-opening discussion about what our bowel movements really say about our underlying health. Combining practical information with light-hearted humor, the Poop Chronicles are chock full of digestive wisdom. For example, in the world of healthy poop, size does matter.

16 Feb 2010

Meda publishes 2009 year-end report

“The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”

16 Feb 2010

Over 96% of SIDS cases due to known risk factors

Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.

16 Feb 2010

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

Lung Cancer Alliance (LCA) announced today a new internet link with a renown lung cancer research center at the 5th Affiliated Hospital of Sun Yat-Sen University, in Zhuhai, China.

15 Feb 2010

Any new pressure in upper body can signal heart attack

Not everyone who suffers a heart attack clutches their chest and falls to the floor. "I woke up and felt like a pill was stuck in my throat," says Betsy, a 68-year-old patient from Upper Providence. "I was taking antibiotics at the time and really didn't think much of it," she adds. "So I tried drinking water and when the "stuck" feeling didn't go away after 45 minutes, I thought something might be wrong."

15 Feb 2010

Senomyx prices common stock offering at $2.80 per share

Senomyx, Inc. announced today the pricing of an underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $2.80 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $20.0 million. The offering is expected to close on or about February 18, 2010, subject to customary closing conditions. Senomyx has also granted the underwriters a 30-day option to purchase up to an aggregate of 1,071,428 additional shares of common stock to cover over-allotments, if any.

15 Feb 2010

U.S. SEC declares Unilife's Form 10 registration statement effective

Unilife Corporation today announced that the US Securities and Exchange Commission (SEC) declared the Company's Form 10 registration statement effective, clearing the path for Unilife Corporation's listing on the NASDAQ.

12 Feb 2010

Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs'

For years, doctors have warned patients to finish their antibiotic prescriptions or risk a renewed infection by a "superbug" that can mount a more powerful defense against the same drug. But a new study by Boston University biomedical engineers indicates that treating bacteria with levels of antibiotics insufficient to kill them produces germs that are cross-resistant to a wide range of antibiotics.

12 Feb 2010

Website News and Research

Dartmouth Atlas hospital ratings could be misleading, says former CMS Senior Policy Advisor

URAC to conduct workshop highlighting multiple aspects of medication adherence

Results indicate deficiencies in end-of-life care across U.S.

Fourth-quarter and full-year 2009 results announced by Health Grades

The Ensign Group announces record $542.0M total revenue for full-year 2009

FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD

CDA, OneAmerica Financial Partners to educate American workforce on disability planning

Siemens Healthcare to host first free Virtual Healthcare IT Conference on the use of EHR

Canada's first-ever national physiotherapy advertising campaign

Sirona Dental Systems files prospectus supplement to its existing shelf registration statement

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Digestive care expert Brenda Watson's website discusses bowel movements and underlying health

Meda publishes 2009 year-end report

Over 96% of SIDS cases due to known risk factors

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

Any new pressure in upper body can signal heart attack

Senomyx prices common stock offering at $2.80 per share

U.S. SEC declares Unilife's Form 10 registration statement effective

Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs'

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News